Suxia Bao
Fudan University
11 Papers
37 Citations
Suxia Bao is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatitis B virus & Medicine. The author has an hindex of 7, co-authored 9 publications.
Chat about Author
Papers
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave
Guanzhu Lu,Yi Zhang,Haocheng Zhang,Jing-Wen Ai,Liu He,Xiaoling Yuan,Suxia Bao,Xiaohua Chen,Hongyu Wang,Jia Cai,Sen Wang,Wen Zhang,Jie Xu +12 more
TL;DR: It was demonstrated that in the elderly older than 60 years old, older age (aged over 80), cerebrovascular disease, and chronic kidney disease were risk factors for severe infection, and fully vaccination was a significant protective factor against severe infections.
69
Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
Suxia Bao,Jianming Zheng,Ning Li,Chong Huang,Mingquan Chen,Qi Cheng,Qian Li,Qing Lu,Mengqi Zhu,Qingxia Ling,Kangkang Yu,Shengshen Chen,Guangfeng Shi +12 more
TL;DR: IL-23 in serum and MoDCs is significantly elevated in HBV-ACLF patients, TRAF6/NF-κB may play a role in IL-23 production by Mo DCs in HBv-AClF patients and high pre-treatment IL- 23 levels in MoDC’s are associated with mortality in HBVs patients.
23
Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients
Shengsen Chen,Qingxia Ling,Kangkang Yu,Chong Huang,Ning Li,Jianming Zheng,Suxia Bao,Qi Cheng,Mengqi Zhu,Mingquan Chen +9 more
TL;DR: It is found that patients with total scores of >2 and >1 were more likely to relapse and succumb to the disease than patients whose total scores were ≤2 and ≤1, and the risk scoring system is useful for predicting the survival of liver cancer patients after tumor resection.
20
The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review).
TL;DR: The findings indicated that Th17-secreted cytokines function by activating or silencing hepatic stellate cells, modulating proinflammatory and pro- or antifibrogenic effectors, regulating extracellular matrix formation, upregulating chemokine expression, and inducing hepatocellular damage or hepatoprotection during the HBV-LC process.
The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.
Shengsen Chen,Kangkang Yu,Chong Huang,Ning Li,Jianming Zheng,Suxia Bao,Mingquan Chen,Wenhong Zhang +7 more
TL;DR: The prediction model, including digestive symptoms, jaundice, TBIL, and DBIL, established in this study is really an excellent predictive tool for non-recovery of DILI patients.
12